Elixirgen Therapeutics, Inc. raises $4 million in Series A funds

BALTIMORE, July 9, 2018 – Elixirgen Therapeutics, Inc. raised $4 million in a Series A funding round from University of Tokyo Edge Capital (UTEC). Elixirgen Therapeutics, Inc. is a biotechnology company founded by Minoru Ko, M.D., Ph.D., that is focused on curing humanity’s ailments through innovations in stem cell biology. Elixirgen Therapeutics is pursuing cures […]

Elixirgen awarded SBIR Phase I grant

BALTIMORE, August 5, 2016 – Elixirgen has awarded the Small Business Innovation Research (SBIR) Phase I Grant from National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH).